AstraZeneca is withdrawing its Covid 'vaccine' worldwide, months after admitting it could cause life-threatening injuries.
The big pharma giant recently admitted in court documents that its vaccine, originally called Covishield, could cause rare side effects such as blood clots and low platelet counts.
The admission came after the company was hit with a class-action lawsuit in the United Kingdom that claimed the vaccine caused at least 81 deaths and hundreds of serious injuries.
The Independent reports: The British-Swedish drugmaker has already withdrawn its EU marketing authorisation for the vaccine, branded Vaxzevria since 2021. The authorisation is the approval to market a drug in EU’s member states. The withdrawal was due to a “surplus of available updated vaccines” against new variants of the novel coronavirus, the company said.
The application to withdraw the vaccine from the EU was made on 5 March and came into effect on 7 May.
The admission came after the company was slapped with a class action lawsuit in the UK which claimed that the vaccine had caused deaths and severe injuries and sought damages up to £100m for about 50 victims.
“It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known,” AstraZeneca said in court documents in February, the newspaper reported.
TTS is Thrombosis with Thrombocytopenia Syndrome, which is characterised by blood clots and low blood platelet counts in humans.
AstraZeneca’s vaccine was developed in collaboration with Oxford University and produced by the Serum Institute of India. It was widely administered in over 150 countries, including Britain and India.
Remember this:
As #AstraZeneca is pulled worldwide for killing too many people, I remind you of the standing ovation the inventor got at Wimbledon....(that sheepish look reads a little differently now...).
— Bev Turner 🌸 (@beverleyturner) May 7, 2024
Drugs take years to develop safely.
But that was suddenly irrelevant in the face of… https://t.co/S41AjFDMkV pic.twitter.com/WI9B5cmUKV
